MedTrace Logo

A Study to Test How BI 1819479 is Taken up and Processed by the Body

NCT07065617 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2026-03-17

No results posted yet for this study

Summary

This trial is intended to investigate the mass balance, metabolism, and basic pharmacokinetics of BI 1819479 (C-14) (Part A) and to investigate the absolute bioavailability of BI 1819479 (Part B) in healthy male volunteers.

Conditions

  • Healthy

Interventions

DRUG

[14C]BI 1819479

\[14C\]BI 1819479

DRUG

BI 1819479

BI 1819479

DRUG

BI 1819479 (C-14)

BI 1819479 mixed with \[14C\]BI 1819479

Sponsors & Collaborators

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-04
Primary Completion
2025-10-04
Completion
2025-11-04

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07065617 on ClinicalTrials.gov